mortality/aging
• mice do not survive past 14 months, displaying a spectrum of hematologic malignancies at time of death, with individual mice exhibiting various leukemias or myelodysplastic syndrome (MDS)
|
hematopoietic system
• peripheral blood cytopenia and dysplasia are observed in mutants
|
• bone marrow shows increased apoptosis compared to control littermates at 5 months
|
• bone marrow (from tibia or femur) is hypercellular (total number of nucleated cells) in some mice at 5 months
|
• dysplastic megakaryocytes with hypolobulated nuclei and increased nuclear-cytoplasmic ratios are observed in bone marrow of mutants but not in controls at 5 months
|
• dysplastic multinucleated erythroblasts are observed bone marrow of mutants at 5 months but not in controls; some erythroblasts with clefted nuclei are observed
|
• numbers of erythroblasts in bone marrow is higher than in controls
|
• mutants show trend (not statistically significant) to increased mean cell volume
|
• circulating nucleated red blood cells are seen seen in peripheral blood smears from animals at 4 to 7 months
|
anisocytosis
(
J:107446
)
• seen in peripheral blood smears from animals at 4 to 7 months
|
• seen in peripheral blood smears from animals at 4 to 7 months
|
• seen in peripheral blood smears from animals at 4 to 7 months
|
• hypersegmented neutrophils are seen in peripheral blood smears from animals at 4 to 7 months
|
• giant platelets are seen in peripheral blood smears from animals at 4 to 7 months
|
• compared to littermate controls at 4 to 7 months
|
neoplasm
• at time of death (around or before 14 months), some animals develop megakaryocytic leukemia, erythroid leukemia, undifferentiated leukemia, myeloid leukemia with maturation, and precursor-T lymphoblastic lymphoma/leukemia (pre-T LBL) or pre-malignant myelodysplastic syndrome (MDS)
|
immune system
• hypersegmented neutrophils are seen in peripheral blood smears from animals at 4 to 7 months
|
• compared to littermate controls at 4 to 7 months
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
myelodysplastic syndrome | DOID:0050908 |
OMIM:614286 |
J:107446 |